swish30

CLRB - Spiker that could spike on Phase 2 data

Long
NASDAQ:CLRB   Cellectar Biosciences, Inc.
Waiting for Phase 2 data to restart the hype for this low floater.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.